All the news Showing 10 of 39 articles from: Harm reduction interventions and policyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Increase in clean needle and syringe provision essential for hepatitis C elimination Keith Alcorn / 12 February 2020 Elimination of hepatitis C will not be achievable without substantial improvements in provision of sterile injecting equipment, Dr Magdalena Harris of London School of Hygiene and Tropical Medicine told a conference on hepatitis ... London: hepatitis C elimination depends on testing scale-up Keith Alcorn / 28 January 2020 London needs to step up the rate of testing for hepatitis C if it is to achieve elimination of hepatitis C, Professor Graham Foster of Queen Mary University London told the London ... Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs Keith Alcorn / 24 January 2020 Intensive peer support during engagement with hepatitis C care was associated with a high level of engagement in care among vulnerable people including recently homeless people and people who inject drugs in London, ... Prescribers of opioid substitutes lack funding, facilities and guidelines to treat hepatitis C, global survey reveals Keith Alcorn / 24 June 2019 Only 30% of physicians who prescribe opioid substitution therapy to people who inject drugs have also prescribed direct-acting antivirals, despite being ideally placed to offer testing and treatment for hepatitis C, an international ... World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Keith Alcorn / 30 April 2019 The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people who inject drugs and people in prisons. In an analysis ... HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers Keith Alcorn / 11 March 2019 High rates of reinfection in people who inject drugs are a sign that access to treatment is improving, not a sign of failure, and should prompt retreatment, not stigmatisation, Australian hepatitis researcher ... Tackling HIV and hepatitis C in Europe: towards minimum standards Gus Cairns / 11 February 2019 Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of a European-wide ... Lancet commission sets agenda for the elimination of viral hepatitis Keith Alcorn / 10 January 2019 Viral hepatitis leads to around 1.3 million deaths a year, approximately 257 million people are living with hepatitis B virus (HBV) and 71 million with hepatitis C virus (HCV). Viral hepatitis ... Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs Michael Carter / 26 November 2018 Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive